Skip to main content
. 2025 Dec 2;15(6):206. doi: 10.3390/jox15060206
4OHT 4-hydroxytamoxifen
AhR Aryl hydrocarbon receptor
AKT Protein kinase B
AMPK AMP-activated protein kinase
ARNT Aryl hydrocarbon receptor nuclear translocator
CYP Cytochrome P450
DM Diabetes mellitus
EGFR Epidermal growth factor receptor
FGF21 Fibroblast growth factor 21
FICZ 6-Formylindolo[3,2-b]carbazole
GDM Gestational diabetes mellitus
GIP glucose-dependent insulinotropic polypeptide
GLP-1 Glucagon-like peptide-1
GLUTs Sodium-independent glucose transporters
GR Glucocorticoid receptor
HIF-1 Hypoxia-inducible factor-1
IRs Insulin receptors
IRS Insulin receptor substrates
MAPK Mitogen-activated protein kinases
mTORC1 Mammalian target of rapamycin complex 1
NAFLD Non-alcoholic fatty liver disease
Nrf2 NF-E2 p45-related factor
PAHs Polycyclic aromatic hydrocarbons
PCOS Polycystic ovary syndrome
PI3K Phosphoinositide-3-kinase
PKC Protein kinase C
PPARα Peroxisome proliferator-activated receptor α
PPI Proton pump inhibitor
PXR Pregnane X receptor
S1P Sphingosine-1-phosphate
SGLTs Sodium-dependent glucose transporters
T1DM Type 1 diabetes mellitus
T2DM Type 2 diabetes mellitus
TADs Transcriptional activation domains
TCDD 2,3,7,8-tetrachlorodibenzodioxin
TDO Tryptophan-2,3-dioxygenase
TSP-1 Thrombospondin-1
UV Ultraviolet
VISTA V-domain Ig suppressor of T cell activation
XREs Xenobiotic response elements